Bratlley Alexis Fernandez Hernandez | Molecular and Cellular Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Bratlley Alexis Fernandez Hernandez | Molecular and Cellular Neuroscience | Research Excellence Award

Dr. Bratlley Alexis Fernandez Hernandez | Fundación Santa Fe de Bogotá | Colombia

Bratlley Alexis Fernandez Hernandez is a physician and pediatric researcher at Fundación Santa Fe de Bogotá, with expertise in pediatric respiratory diseases and sleep medicine. His clinical and research work focuses on rare pediatric lung conditions, respiratory infections, and sleep disorders, with the goal of improving early recognition, diagnosis, and management in children. He has contributed to pediatric pulmonology through a peer-reviewed publication on Neuroendocrine Hyperplasia of Infancy (NEHI) in Pediatric Pulmonology. In addition to his scientific research, he is a contributing author to the textbook Pediatría: Diagnóstico y Tratamiento. His research projects include clinical characterization of NEHI, retrospective studies on Mycoplasma pneumoniae infections, validation of pediatric sleep questionnaires in Colombian populations, and investigations into the relationship between obstructive sleep apnea and enuresis in children living at high altitude.

View Orcid Profile
Featured Publication


Characteristics of Pediatric Patients With Neuroendocrine Cell Hyperplasia at a Tertiary Care Center in a High‐Altitude City

– María Camila Ortiz‐Pérez; Alexis Fernández‐Hernández; Daniela Cleves; Juliana Cáceres Montejo; Patricia Panqueva; Sonia Restrepo‐Gualteros,
Pediatric Pulmonology

Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Joshua Barzilay | Clinical Neuroscience | Best Researcher Award

Kaiser Permanente of Georgia, Emory School of Medicine | United States

Dr. Joshua I. Barzilay is a senior clinician–scientist and board-certified endocrinologist whose research spans diabetes, hypertension, cardiovascular disease, metabolic syndrome, and aging, integrating epidemiology with long-term clinical outcomes. His early work included oncology and hematology research, followed by a sustained focus on endocrine and metabolic disorders during his tenure at Kaiser Permanente of Georgia and Emory University School of Medicine. Dr. Barzilay has made influential contributions to large, multicenter clinical and population-based studies, including ALLHAT, ACCORD/ACCORDION, and the Cardiovascular Health Study, where he has served on steering committees and specialty working groups. His research has clarified the impact of glucose dysregulation, insulin resistance, and antihypertensive therapies on cardiovascular morbidity, mortality, and incident diabetes, particularly in older adults. A major theme of his work is the relationship between metabolic syndrome, frailty, autonomic function, and cardiovascular risk, providing evidence to guide treatment strategies in complex patients. In addition to his research, Dr. Barzilay has played a key role in national diabetes and hypertension guideline development, medical education, and dissemination of evidence-based care, shaping clinical practice across endocrinology and primary care.

Citation Metrics (Scopus)

25000
20000
15000
10000
0

Citations
24,155

Documents
186
h-index
58

Citations

Documents

h-index


View Scopus Profile
 View Google Scholar Profile

Featured Publications

Yun Hou | Neurodegenerative Disease | Research Excellence Award

Published on by Neuroscientists

Prof. Yun Hou | Neurodegenerative Disease | Research Excellence Award

Prof. Yun Hou | Binzhou Medical University | China

Hou Yun is an Associate Professor and Master’s Supervisor at Binzhou Medical University, recognized for his advancing contributions to neurodegeneration research, stem cell applications, and aging-related therapeutics. His work integrates molecular biology, neuropharmacology, and regenerative medicine to uncover mechanisms underlying neuronal survival, neuroinflammation, and degeneration, while also exploring stem cell-based interventions for anti-aging. As a member of the Youth Committee of the Shandong Anatomical Society and a reviewer for the National Natural Science Foundation of China, he plays an active role in the scientific community. His recent publications provide insight into targeted therapeutic pathways, including studies revealing how novel pyrimidine derivatives suppress glioma growth via miR-873-3p regulation and how hydroxytyrosol counteracts pollutant-induced NF-κB pathway activation, oxidative stress, and neuronal apoptosis. With 51 published documents, an h-index of 21, and 1,658 citations across 1,354 citing documents, his body of work reflects sustained scientific impact and productivity in neurodegenerative disease mechanisms and intervention strategies. His ongoing research continues to advance understanding of neuronal resilience, disease-modifying pathways, and innovative biomedical approaches to combat aging and neurodegeneration.

Profile: Scopus

Featured Publications

Lavender: phytochemistry, pharmacology, cross-disciplinary applications, and clinical efficacy. (2025). Phytomedicine.

Novel 3,4-dihydronaphthalen-1(2H)-one derivatives promote apoptosis and inhibit migration of hepatocellular carcinoma cells via inhibition of NF-κB and MAPK signaling pathways. (2025). European Journal of Medicinal Chemistry.

Hydroxytyrosol inhibits BPS-induced NF-κB signaling pathway activation, mitigates oxidative stress, and reduces neuronal apoptosis. (2025). Journal of Biochemical and Molecular Toxicology.

Elucidating the mechanism of 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine-induced inhibition of glioma growth through miR-873-3p. (2025). Molecular Carcinogenesis.

The crystal structure of methyl ((4-aminobenzyl)sulfonyl)-D-prolinate, C13H18N2O4S. (2024). Zeitschrift für Kristallographie – New Crystal Structures.